A flexural exanthem following postexposure prophylaxis.
Journal
Clinical and experimental dermatology
ISSN: 1365-2230
Titre abrégé: Clin Exp Dermatol
Pays: England
ID NLM: 7606847
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
revised:
31
01
2022
received:
10
08
2021
accepted:
09
02
2022
pubmed:
18
3
2022
medline:
7
6
2022
entrez:
17
3
2022
Statut:
ppublish
Résumé
We report a case of symmetrical drug-related intertriginous and flexural exanthema following antiretroviral postexposure prophylactic medications, tenofovir and emtricitabine, commencement of which preceded the onset of the rash. Tenofovir and emtricitabine are both nucleoside reverse transcriptase inhibitor medications, commonly used to prevent development of AIDS.
Identifiants
pubmed: 35297086
doi: 10.1111/ced.15131
pmc: PMC9313790
doi:
Substances chimiques
Tenofovir
99YXE507IL
Emtricitabine
G70B4ETF4S
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
1204-1206Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022 The Authors. Clinical and Experimental Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
Références
Contact Dermatitis. 2004 Nov-Dec;51(5-6):297-310
pubmed: 15606657
Contact Dermatitis. 2018 Dec;79(6):378-380
pubmed: 30062790
Indian J Dermatol. 2013 May;58(3):244
pubmed: 23723506
BMJ Case Rep. 2013 Nov 28;2013:
pubmed: 24287484
J Cutan Pathol. 2021 Dec;48(12):1471-1479
pubmed: 34159622
Am J Clin Dermatol. 2011 Jun 1;12(3):171-80
pubmed: 21469762